Search Results - Ulrich Herrlinger

Refine Results
  1. 1
    High-dose methotrexate toxicity in elderly patients with primary central nervous system lymphoma

    High-dose methotrexate toxicity in elderly patients with primary central nervous system lymphoma by Kristoph Jahnke, Agnieszka Korfel, Peter Martus, Michael Weller, Ulrich Herrlinger, Alexander Schmittel, L. Fischer, E. Thiel

    Published 2005
    Get full text
    Artigo
    Save to List
    Saved in:
  2. 2
    Vessel Wall Contrast Enhancement: A Diagnostic Sign of Cerebral Vasculitis

    Vessel Wall Contrast Enhancement: A Diagnostic Sign of Cerebral Vasculitis by Wilhelm Küker, Susanne Gaertner, Thomas Nägele, Christian Dopfer, M. Schöning, Jens Fiehler, Peter M. Rothwell, Ulrich Herrlinger

    Published 2008
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  3. 3
    Efficacy and Tolerability of Temozolomide in an Alternating Weekly Regimen in Patients With Recurrent Glioma

    Efficacy and Tolerability of Temozolomide in an Alternating Weekly Regimen in Patients With Recurrent Glioma by Antje Wick, Jörg Felsberg, Joachim P. Steinbach, Ulrich Herrlinger, Michael Platten, Britta Blaschke, Richard Meyermann, Guido Reifenberger, Michael Weller, Wolfgang Wick

    Published 2007
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  4. 4
    Neural Precursor Cells for Delivery of Replication-Conditional HSV-1 Vectors to Intracerebral Gliomas

    Neural Precursor Cells for Delivery of Replication-Conditional HSV-1 Vectors to Intracerebral Gliomas by Ulrich Herrlinger, Christian Woiciechowski, Miguel Sena‐Esteves, Karen S. Aboody, Andreas H. Jacobs, Nikolai G. Rainov, Evan Y. Snyder, Xandra O. Breakefield

    Published 2000
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  5. 5
    Unsupervised consensus cluster analysis of [18F]-fluoroethyl-L-tyrosine positron emission tomography identified textural features for the diagnosis of pseudoprogression in high-grade glioma

    Unsupervised consensus cluster analysis of [18F]-fluoroethyl-L-tyrosine positron emission tomography identified textural features for the diagnosis of pseudoprogression in high-gra... by Sied Kebir, Zain Khurshid, Florian Gaertner, Markus Essler, Elke Hattingen, Rolf Fimmers, Björn Scheffler, Ulrich Herrlinger, Ralph A. Bundschuh, Martin Glas

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  6. 6
    The Colony Stimulating Factor-1 Receptor (CSF-1R)-Mediated Regulation of Microglia/Macrophages as a Target for Neurological Disorders (Glioma, Stroke)

    The Colony Stimulating Factor-1 Receptor (CSF-1R)-Mediated Regulation of Microglia/Macrophages as a Target for Neurological Disorders (Glioma, Stroke) by Cristina Barca, Claudia Foray, Sven Hermann, Ulrich Herrlinger, Isabel Remory, Damya Laoui, Michael Schäfers, Oliver Grauer, Bastian Zinnhardt, Andreas H. Jacobs

    Published 2021
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  7. 7
    Quantitative T1‐mapping detects cloudy‐enhancing tumor compartments predicting outcome of patients with glioblastoma

    Quantitative T1‐mapping detects cloudy‐enhancing tumor compartments predicting outcome of patients with glioblastoma by Andreas Müller, Alina Jurcoane, Sied Kebir, Philip Ditter, Felix Schrader, Ulrich Herrlinger, Theophilos Tzaridis, Burkhard Mädler, Hans H. Schild, Martin Glas, Elke Hattingen

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  8. 8
    Long-Term Survival of Patients With Glioblastoma Treated With Radiotherapy and Lomustine Plus Temozolomide

    Long-Term Survival of Patients With Glioblastoma Treated With Radiotherapy and Lomustine Plus Temozolomide by Martin Glas, Caroline Happold, Johannes Rieger, Dorothee Wiewrodt, Oliver Bähr, Joachim P. Steinbach, Wolfgang Wick, Rolf‐Dieter Kortmann, Guido Reifenberger, Michael Weller, Ulrich Herrlinger

    Published 2009
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  9. 9
    Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine PET imaging for the detection of checkpoint inhibitor-related pseudoprogression in melanoma brain metastases

    Dynamic O-(2-[18F]fluoroethyl)-L-tyrosine PET imaging for the detection of checkpoint inhibitor-related pseudoprogression in melanoma brain metastases by Sied Kebir, Laurèl Rauschenbach, Norbert Galldiks, Max Schlaak, Elke Hattingen, Jennifer Landsberg, Ralph A. Bundschuh, Karl‐Josef Langen, Björn Scheffler, Ulrich Herrlinger, Martin Glas

    Published 2016
    Get full text Get full text
    Carta
    Save to List
    Saved in:
  10. 10
    Chemoradiotherapy of Newly Diagnosed Glioblastoma With Intensified Temozolomide

    Chemoradiotherapy of Newly Diagnosed Glioblastoma With Intensified Temozolomide by Markus Weiler, Christian Hartmann, Dorothee Wiewrodt, Ulrich Herrlinger, Thierry Gorlia, Oliver Bähr, Richard Meyermann, Michael Bamberg, Marcos Tatagiba, Andreas von Deimling, Michael Weller, Wolfgang Wick

    Published 2009
    Get full text
    Artigo
    Save to List
    Saved in:
  11. 11
    Phase II Trial of Temsirolimus for Relapsed/Refractory Primary CNS Lymphoma

    Phase II Trial of Temsirolimus for Relapsed/Refractory Primary CNS Lymphoma by Agnieszka Korfel, Uwe Schlegel, Ulrich Herrlinger, Martin Dreyling, Christian Schmidt, L. von Baumgarten, Antonio Pezzutto, Thomas Grobosch, Sied Kebir, Eckhard Thiel, Peter Martus, Philipp Kiewe

    Published 2016
    Get full text
    Artigo
    Save to List
    Saved in:
  12. 12
    The Alcatraz‐Strategy: a roadmap to break the connectivity barrier in malignant brain tumours

    The Alcatraz‐Strategy: a roadmap to break the connectivity barrier in malignant brain tumours by Matthias Schneider, Anna‐Laura Potthoff, Georg Karpel‐Massler, Patrick Schuss, Markus D. Siegelin, Klaus‐Michael Debatin, Hugues Duffau, Hartmut Vatter, Ulrich Herrlinger, Mike‐Andrew Westhoff

    Published 2024
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  13. 13
    Vemurafenib for Leptomeningeal Melanomatosis

    Vemurafenib for Leptomeningeal Melanomatosis by Niklas Schäfer, Björn Scheffler, Moritz Stuplich, Christina Schaub, Sied Kebir, Claudia Rehkämper, Frederick Mack, Pitt Niehusmann, Matthias Simon, Susanne Greschus, K. Kuchelmeister, Ulrich Herrlinger, Martin Glas

    Published 2013
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  14. 14
    Newly diagnosed glioblastoma in geriatric (65 +) patients: impact of patients frailty, comorbidity burden and obesity on overall survival

    Newly diagnosed glioblastoma in geriatric (65 +) patients: impact of patients frailty, comorbidity burden and obesity on overall survival by Matthias Schneider, Anna‐Laura Potthoff, Elisa Scharnböck, Muriel Heimann, Niklas Schäfer, Johannes Weller, Christina Schaub, Andréas H. Jacobs, Erdem Güresir, Ulrich Herrlinger, Hartmut Vatter, Patrick Schuss

    Published 2020
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  15. 15
    Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors

    Longitudinal heterogeneity in glioblastoma: moving targets in recurrent versus primary tumors by Niklas Schäfer, Gerrit H. Gielen, Laurèl Rauschenbach, Sied Kebir, Andreas Till, Roman Reinartz, Matthias Simon, Pitt Niehusmann, Christoph Kleinschnitz, Ulrich Herrlinger, Torsten Pietsch, Björn Scheffler, Martin Glas

    Published 2019
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  16. 16
    Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma—results from the DIRECTOR trial

    Complete resection of contrast-enhancing tumor volume is associated with improved survival in recurrent glioblastoma—results from the DIRECTOR trial by Bogdana Suchorska, Michael Weller, Ghazaleh Tabatabai, Christian Senft, Peter Hau, Michael Sabel, Ulrich Herrlinger, Ralf Ketter, Uwe Schlegel, Christine Marosi, Guido Reifenberger, Wolfgang Wick, Jörg C. Tonn, Hans‐Georg Wirsching

    Published 2016
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  17. 17
    Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas

    Neural stem cells display extensive tropism for pathology in adult brain: Evidence from intracranial gliomas by Karen S. Aboody, Alice B. Brown, Nikolai G. Rainov, Kate A. Bower, Shaoxiong Liu, Wendy Yang, Juan E. Small, Ulrich Herrlinger, Václav Ourednik, Peter McL. Black, Xandra O. Breakefield, Evan Y. Snyder

    Published 2000
    Get full text
    Artigo
    Save to List
    Saved in:
  18. 18
    Current status and perspectives of interventional clinical trials for glioblastoma – analysis of ClinicalTrials.gov

    Current status and perspectives of interventional clinical trials for glioblastoma – analysis of ClinicalTrials.gov by Nikola Čihorić, Alexandros Tsikkinis, Giuseppe Minniti, Frank J. Lagerwaard, Ulrich Herrlinger, Etienne Mathier, Ivan Soldatović, Branislav Jeremić, Pirus Ghadjar, Olgun Eliçin, Kristina Lössl, Daniel M. Aebersold, Claus Belka, Evelyn Herrmann, Maximilian Niyazi

    Published 2017
    Get full text Get full text
    Revisão
    Save to List
    Saved in:
  19. 19
    SD-208, a Novel Transforming Growth Factor β Receptor I Kinase Inhibitor, Inhibits Growth and Invasiveness and Enhances Immunogenicity of Murine and Human Glioma Cells<b><i>In vitro</i></b>and<b><i>In vivo</i></b>

    SD-208, a Novel Transforming Growth Factor β Receptor I Kinase Inhibitor, Inhibits Growth and Invasiveness and Enhances Immunogenicity of Murine and Human Glioma Cells<b><i>In vitr... by Martin Uhl, Steffen Aulwurm, Jörg Wischhusen, Markus Weiler, Ying Jing, Ramona G. Almirez, Ruban Mangadu, Yu-Wang Liu, Michael Platten, Ulrich Herrlinger, Alison Murphy, Darren H. Wong, Wolfgang Wick, Linda S. Higgins, Michael Weller

    Published 2004
    Get full text Get full text
    Artigo
    Save to List
    Saved in:
  20. 20
    Phase II Trial of Lomustine Plus Temozolomide Chemotherapy in Addition to Radiotherapy in Newly Diagnosed Glioblastoma: UKT-03

    Phase II Trial of Lomustine Plus Temozolomide Chemotherapy in Addition to Radiotherapy in Newly Diagnosed Glioblastoma: UKT-03 by Ulrich Herrlinger, Johannes Rieger, Dorothee Koch, Simon Loeser, Britta Blaschke, Rolf‐Dieter Kortmann, Joachim P. Steinbach, Thomas Hundsberger, Wolfgang Wick, Richard Meyermann, Ta-Chih Tan, Clemens Sommer, Michael Bamberg, Guido Reifenberger, Michael Weller

    Published 2006
    Get full text Get full text
    Artigo
    Save to List
    Saved in:

Search Tools: